Argenx Se (ARGX) Income from Continuing Operations (2016 - 2026)
Argenx Se (ARGX) reported Income from Continuing Operations of $570 million for Q3 2026, up 33.2% from $428 million a year earlier and up 61.5% from the prior quarter.
Powered by 
Analysis
Argenx Se (ARGX) Income from Continuing Operations (2016 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Argenx Se's Income from Continuing Operations came in at $1.68 billion, up 331.1% year-over-year; for FY2025, it was $1.29 billion, up 55.1% from FY2024.
- By year, Income from Continuing Operations came in at $833.04 million in FY2024, -$295.05 million in FY2023, -$709.59 million in FY2022 and -$408.27 million in FY2021.
- The Q3 2026 figure ranks as the highest quarterly Income from Continuing Operations in data going back to Q3 2016.
- Year over year, Income from Continuing Operations has now increased in each of the last three quarters, with growth averaging 138.3% over the last four quarters.
- Per Business Quant data, the three quarters before Q3 2026 came in at $353 million (Q2 2026), $486 million (Q1 2026) and $273.64 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Argenx Se | 56.96 Bn | 56.96 Bn | 1.56 Bn | 570.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 570.00 Mn |
| Jun 30, 2026 | 353.00 Mn |
| Mar 31, 2026 | 486.00 Mn |
| Dec 31, 2025 | 273.64 Mn |
| Sep 30, 2025 | 428.00 Mn |
| Jun 30, 2025 | 328.44 Mn |
| Mar 31, 2025 | 235.00 Mn |
| Dec 31, 2024 | -601.14 Mn |
| Sep 30, 2024 | 84.64 Mn |
| Jun 30, 2024 | -59.07 Mn |
| Mar 31, 2024 | -87.10 Mn |
| Dec 31, 2023 | -23.18 Mn |
| Sep 30, 2023 | -93.92 Mn |
| Jun 30, 2023 | 446,000.00 |
| Mar 31, 2023 | -123.49 Mn |
| Dec 31, 2022 | -43.86 Mn |
| Sep 30, 2022 | -247.01 Mn |
| Jun 30, 2022 | -203.03 Mn |
| Mar 31, 2022 | -232.96 Mn |
| Dec 31, 2021 | -251.94 Mn |
API Access
Argenx Se Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ARGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "ARGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ARGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();